The CardioPrevent® program is a global risk reduction program that is based on seven years of research conducted through the University of Ottawa Heart Institute by a multidisciplinary team of clinicians and behavioural scientists.
CardioPrevent® provides an evidence-based, tailored primary prevention cardiovascular health program intended for patients at a moderate to high risk of developing cardiovascular disease (CVD). It provides physicians with a systematic process to screen and identify at risk individuals and link them to a personalized primary prevention program.
Learn more about the details of the CardioPrevent® Program.
To lower the risk of CVD development in individuals who may be at a moderate to high risk.
- To support health care providers through the deployment of CVD preventive care models to support lifestyle screening, behavioural counseling, and community linkages.
- To improve accessibility to CVD risk screening and risk management through community outreach.